Skip to content
New Data on CHC with MwA episode artwork

Oct 2, 2026 24 min

New Data on CHC with MwA

from Dr. Chapa’s OBGYN Clinical Pearls Hosted by Dr. Chapa’s Clinical Pearls

Currently, the CDC U.S. Medical Eligibility Criteria (USMEC) rate CHCs as category 4 (unacceptable health risk) for migraine with aura, versus category 2 for migraine without aura; ACOG similarly recommends avoiding estrogen-containing contraception in migraine with aura. But, recent data published in August 2026 from the UK seems to show no increased risk with “modern”/low-dose combination birth control pills when compared to progesterone only options. Is the CDC contraindication out outdated? Not quite. Listen in for details. 1. https://www.podcastrepublic.net/podcast/1412385746Ihara K, et al. Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database study. Cephalalgia. 2025 Dec;45(12):3331024251404924. doi: 10.1177/03331024251404924. Epub 2025 Dec 17. 2. Gibbs LR, Fox MP, Aparicio HJ, Jick S. Combined Oral Contraceptives and Stroke Risk in Individuals With Migraine With Aura. Obstet Gynecol. 2026 Aug 1;148(2):160-170. doi: 10.1097/AOG.0000000000006306. Epub 2026 May 7.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

New Data on CHC with MwA

0:00 24:34

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?

This episode is 24 minutes long.

When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?

This episode was published on October 2, 2026.

Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.